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Abstract 
Brunescent (dark brown) cataract is particularly prevalent in the tropics. Enzymatic digestion of the insoluble protein fraction of brunescent 
cataractous eye lenses from India, followed by high performance liquid chromatographic separation of the pigments and spectroscopic investigations, 
have led to the identification of one of the pigments as 4-hydroxyquinoline-3-[a-aminoacetic acid] (compound A). The 4-hydroxyquinoline moiety 
is shown to be a photodynamic agent that generates O;- and leads to protein crosslinking. This suggests that the compound A may play a long-term 
deleterious role in situ in the lens. 
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1. Introduction 
The normal mammalian eye lens is a transparent body 
made up of long enucleated fiber-shaped cells of epithe- 
lial origin which, during differentiation, rid themselves 
of large organelles that are likely to scatter light, and 
over-express structural proteins, called crystallins, to 
very high intracellular concentrations (20&500 mg/ml). 
These highly concentrated crystallin solutions minimize 
light scattering through short-range ordering of mole- 
cules into a glass-like state. A reduction in light-scatter- 
ing is also achieved through regular intercellular stacking 
of the hexagonally cross-sectioned fiber cells. Thus, the 
lens owes its transparency, as well as its other optical 
properties (such as the existence of a smooth radial re- 
fractive gradient), to the ordered organization of its con- 
stituents [I]. 
Changes in such molecular ordering, arising from pro- 
tein conformational changes, aggregation and precipita- 
tion, bring about an increase in light scattering through 
particulate protein matter, and through discontinuities 
generated in the radial refractive gradient. Such changes 
tend to be permanent, since there is no turnover of mol- 
ecules in enucleated cells [2]. With aging and chronic 
oxidative stress, crystallins undergo covalent chemical 
modifications leading to the formation of high molecular 
weight aggregates, insoluble protein particles and in- 
creased pigmentation [3-71. Oxidation is believed to re- 
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sult largely from photochemical processes that convert 
aromatic amino acids to potent photosensitizers or sim- 
ple chromophores which absorb near-UV and low wave- 
length visible light. The generation of reactive oxygen 
species by some of these chromophores is thought to lead 
to widespread protein oxidation. Little is known, how- 
ever, about either the covalent nature or age-dependent 
accumulation of the pigments that are generated, or 
about the physiological roles that some of these might 
have in the lens. 
One form of cataract that is particularly prevalent in 
the tropical regions of the world is brunescent or dark 
brown cataract. Epidemiological studies have implicated 
this higher incidence of brunescent cataract to the in- 
creased levels of insolation in the tropics [8-l 11. Brunes- 
cent cataract is characterized by high amounts (as much 
as 70% of the total protein) of insoluble proteins in the 
lens, and pronounced absorption and emission in the 
near-UV and visible regions of the spectrum [12-141. 
Evidence is increasingly gathering to support the sug- 
gestion that tryptophan (Trp) metabolites and photopro- 
ducts constitute at least a fraction of the pigments gener- 
ated in the lens [12,15-201. Some of these that have been 
identified are kynurenine (KY), N-formylkynurenine 
(NFK), 3-hydroxykynurenine (3HK) and its glucoside 
(3HKG), /I-carbolines, and anthranilic acid derivatives 
[ 15,18-20,22,23]. 
In this paper, we report the isolation and structural 
characterization of a novel and hitherto unreported pig- 
ment that accumulates in brunescent cataract lenses ex- 
cised from human patients, namely 4-hydroxyquinoline- 
3-[a-aminoacetic acid] or compound A (see Fig. 3). We 
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further show that the 4-hydroxyquinoline moiety of this 
compound is photodynamic, and generates reactive oxy- 
gen species upon irradiation with UVA light, leading to 
protein crosslinking. This suggests that compound A 
may play a long-term deleterious role in situ in the lens. 
2. Materials and methods 
al. [26], which involves incubation of the reaction mixture with 2-3 mM 
deoxyribose at 37°C. Color development is normally achieved by the 
addition of a 1% solution of thiobarbituric acid (TBA) in 50 mM 
NaOH, followed by heating of the tubes at 100°C for IO-20 min and 
cooling. The resulting TBA adduct was measured by its absorbance at 
532 nm. 
3. Results and discussion 
2.1. Isolation of the pigments 
Brunescent (very dark brown) human lenses excised through cataract 
surgery of elderly (SO-55 year old) patients, obtained from the L.V 
Prasad Eye Institute, Hyderabad, India, were homogenized in water 
and centrifuged at 10,000 x g for 15 min at 4°C. The resulting dark 
brown pellet was solubilized by incubation at 37°C of the pellet with 
an aqueous solution of pronase (Boehringer; 1 mg pronase for every 
100 mg pellet) at neutral pH, so as not to decompose the pigments. After 
24 h, a further 0.5 mg pronase per 100 mg pellet weight was added. After 
48 h, the enzyme leucine aminopeptidase (Sigma; 0.1 mg/lOO mg weight 
of pellet) was added and the digestion ended after 60 h by heating for 
2 min in a boiling water bath. The solution was chromatographed on 
PD-10 desalting columns of Sephadex G-25M to remove the enzymes; 
the mixture of hydrolyzed amino acids and small peptides, generated 
through protease action, was eluted with water and then re-chromato- 
graphed on a Waters C,, reverse-phase column (30 cm x 7.8 mm i.d), 
using a Pharmacia HPLC system. The mobile phase consisted of 5% 
methanol, run isocratically at 1.5 ml/min with absorbance monitored 
at 400 nm. The purity of the eluted fractions was checked on precoated 
Kieselgel TLC plates (silica gel 60 F,,,; supplied by Merck). The solvent 
system used was n-butanol: acetic acid : water (8 : 1 : 2) and the spots 
were visualised by iodine staining or with ninhydrin. 
3.1. Isolation and purification of fluorophores 
The enzyme-digested lenticular material was first 
chromatographed on a Sephadex G-25 column to re- 
move all the enzyme, and the small molecular eluate 
fractions were separated and purified using reverse- 
phase HPLC. Four eluates absorbing at 400 nm were 
collected from the column at retention times of 6.8, 9.9, 
13.5 and 21.3 min. Three of these (9.9, 13.5 and 21.3 min 
fractions) were re-chromatographed on the same system 
and purified to homogeneity. Attempts are being made 
to separate the 6.8 min peak into its individual compo- 
nents. Analysis of the compound eluting at 9.9 min indi- 
cates it to be racemic tyrosine. (NMR and mass spectra 
of the purified fraction that eluted at 9.9 min revealed it 
to be m_-tyrosine. The extent of racemization was esti- 
mated, by measuring its optical rotatory dispersion, to 
2.2. Spectral measurements 
Absorption spectra were recorded on a Hitachi model 330 spectro- 
photometer and fluorescence spectra on a Hitachi model F-4000 spec- 
trotluorimeter. One-dimensional NMR spectra were recorded on a 
AM-300 MHz Bruker machine. Fast atom bombardment (FAB) mass 
spectra were recorded on a JEOL SX 102/DA-6000 mass spectrometer/ 
data system using xenon (6 kV, 10 mA) as the FAB gas, an accelerating 
voltage of 10 kV and m-nitrobenzyl alcohol (NBA) as the matrix. 
2.3. Studies on lens proteins 
Bovine lenses (8-10) were decapsulated and homogenized in 0.1 M 
Tris buffer, pH 7.4, containing 0.5 M NaCl, 1 mM EDTA and 0.1% 
NaN,. The insoluble protein fraction was removed by centrifugation 
(30,000 x g, 30 min) and the supernatant was chromatographed on a 
Sephacryl S-200 gel filtration column (0.04 x 1.8 m) in order to sepa- 
rate the individual a-, BH-, /Jr- and y-crystallins. Each of the crystallins 
was dialysed repeatedly against water and stored in the lyophilized 
form. y-Crystallin was used in the photosensitization studies. Solutions 
were taken in a fluorescence cuvette (1 x 1 x 4 cm) and placed in the 
sample compartment of a Hitachi spectrofluorimeter (model F-4000) 
under conditions of constant stirring, and irradiated with light corre- 
sponding to the absorption band of the photosensitizers included in the 
protein solution, using a monochromator set at a bandwidth of 20 nm 
to restrict light originating from a broad-emitting 150 W Xe arc lamp 
source. The light intensity falling on the sample was estimated to be 
around 2.0-2.4 mW .crn-* (approximately lOi photons. s-‘) in the 295- 
335 nm region, and 3.0 mW ‘cm-* in the 360-365 nm range. Electropho- 
resis was done on 12.5% polyacrylamide gels, using the Pharmacia 
Phastsystem assembly. Protein samples were boiled with sodium do- 
decyl sulfate (SDS) solution containing /3-mercaptoethanol, so as to 
disaggregate the protein and to detect non-disulfide crosslinks. 
150 
A 








250 300 350 
h,(nm) 
011 













. . . 
..’ 
_.. 
350 400 450 500 
The superoxide anion (O;-) was detected using the cytochrome c 
reduction method [24]. Solutions of photosensitizers were illuminated 
in the presence of ferricytochrome c in 50 mM phosphate buffer, pH 
7.4, and the reduction monitored spectrophotometrically at 550 nm, 
using sSOO =20,000 M-’ ‘cm-’ for the reduced-oxidized cytochrome c 
[25]. A concentration of 20 PM was used throughout. The generation 
of hydroxyl radicals (‘OH) was assayed by the method of Halliwell et 
a,bm) k,(nm) 
Fig. 1. Fluorescence analysis of the 21.3 min fraction: (A), excitation 
spectra with the emission monochromator set at 400 nm; (B) excitation 
spectra with the emission monochromator set at 480 nm; (C) emission 
profile upon excitation at 313 nm (-) and 323 nm (....,.); (D) emission 
profile upon excitation at 400 nm. A.U refers to arbitrary units. 
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Fig. 2. 300 MHz ‘H NMR spectrum of (A) the 21.3 min fraction in DMSO and (B) authentic kynurenic acid in DMSO. 
be around 10%. The absorption displayed around 400 
nm is because of its occurrence as a 1: 1 dimeric complex 
in the quinhydrone form [27]. Age-dependent racemiza- 
tion in long-lived protein molecules is known, and has 
been reported in cataract lenses with aspartic acid and 
other amino acid residues [28-301. The structure elucida- 
tion of the 13.6 min fraction is currently in progress.) We 
report here the analysis of the fraction corresponding to 
the peak with a retention time of 21.3 min. 
3.2. Structure of the 21.3 min fraction 
Excitation spectral analysis of the 21.3 min fraction, 
with the emission monochromator set at 400 nm, shows 
a maxima at 313 nm (Fig. 1A) while that with the mon- 
ochromator at 480 nm shows a broad peak at 323 nm 
(Fig. 1B). The emission profiles obtained from excita- 
tions at 313 and 323 nm are shown in Fig. lC, while that 
arising from excitation at 400 nm is shown in Fig. ID. 
The NMR spectrum of a DMSO-d, solution of this 
fraction is presented in Fig. 2A. The spectrum may be 
grouped into five groups of signals: two sets of doublets 
on the low field, two sets of triplets (or rather multiplets) 
around 7 ppm, and a singlet at 7.2 ppm. Such a spectrum 
is characteristic of heterocyclic species, the proton spec- 
tra of which are seriously complicated by the overlapping 
of spectral multiplets. Through a process of both looking 
into the chemistry of modification of Trp, as well as 
comparison of the spectrum with a series of heterocyclic 
species, it was possible to assign the spectrum to a quino- 
line derivative. The presence of a singlet in the spectrum 
implies that the heterocyclic ring of quinoline is substi- 
tuted at two positions. This suggests two possibilities, as 
shown in Fig. 3. One of these molecules is kynurenic acid 
(KUA), which has been implicated in the oxidative path- 
way of Trp. However, the possibility of this fraction 
being KUA was ruled out by the following. Comparison 
with the NMR spectrum of an authentic KUA sample 
(Fig. 2B) shows that while the same sets of signals are 
present, their chemical shifts are quite different. Specifi- 
cally, the position of the singlet can be used to resolve 
the issue, since it originates from the heterocyclic ring of 











Fig. 3. Proposed mechanism for the formation of (A) 4-hydroxyquino- 
line-3-[a-aminoacetic acid] and (B) kynurenic acid (KUA). Pep refers 
to the peptide (backbone) chain. 
the presence of its neighbours. The singlet in the case of 
KUA is at 6.5 ppm while the one in the fraction being 
analysed appears at 7.2 ppm. The CH proton (singlet) 
from compound A would be expected to occur at a 
higher ppm value, being at the a-position of the ring 
nitrogen. (Normally such a proton would appear further 
downfield but the value of the chemical shift is lower in 
this case, which could be attributed to the possibility 
of tautomeric forms of compound A.) Thus the frac- 
tion under consideration seems to be (A) 4-hydroxy- 
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quinoline-3-[a-aminoacetic acid] (or 3-[a-glycyl]-4-hy- 
droxyquinoline), and not (B) kynurenic acid (or 4-hy- 
droxyquinoline-2-carboxylic acid). 
Further confirmation of the structure of this molecule 
comes from the FAB mass spectra shown in Fig. 4. The 
m/z at 218 matches the calculated molecular weight and 
may be attributed to the species, M’, which is commonly 
observed in the positive-ion FAB of organic compounds 
[31]. Positive-ion FAB can yield cationated species such 
as Na’ adducts; the mass at 240 could be one such ad- 
duct. Also, 4-hydroxyquinoline is known to show ab- 
sorption bands at 315 and 328 nm [32], much like the 
excitation bands obtained in the present case (Fig. 1A 
and B). 
According to the mechanism proposed in Fig. 3, it is 
evident that this structure should have existed prior to 
the enzymatic cleavage of the peptide bond and that the 
ring closure may not have happened as a consequence of 
such a bond cleavage, as it would be for molecule B 
(KUA). In this event, the possibility of finding KUA in 
the protein would appear to be remote, since the forma- 
tion of KUA requires that the a-carbon atom of the 
amino acid be available for ring closure after cleavage of 
the peptide bond. The presence of KUA in any lens is yet 
to be confirmed, even though it can arise through the 
oxidative pathway. Thus, if KUA were to be detected in 
the lens, it would arise through the oxidation of free Trp, 
and not from Trp residues present in the protein. 
Irradiation of Trp and of NFK at pH 7.3, using sun- 
light or a ‘daylight lamp’ has been shown to give 4- 
hydroxyquinoline as one of the products [32]. Thus, we 
surmise that the compound A seen in the brown insolu- 
ble portion of the cataract lens from India is the result 
of long-term photochemical modification of the Trp res- 
idues of the lens proteins, although its accumulation 
from ‘dark’ reactions is not to be dismissed. Indeed, the 
parent compound, i.e. 4-hydroxyquinoline, has been de- 
tected as a metabolite of kynurenine in silkworms [33] 
Fig. 4. Fast atom bombardment (FAB) mass spectrum of the 21.3 min fraction with m/z at 218. FAB gas was xenon (6 kV, 10 mA), accelerating 
voltage was 10 kV and the spectrum was recorded at room temperature. 
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Fig. 5. SDS-PAGE patterns of 1 mg/ml solutions of bovine ycrystalhn, 
irradiated for a period of 1 h each, using a Hitachi F-4000 spectrofluori- 
meter light source with monochromator set at the respective wave- 
lengths, slit 20 nm. Lane 1, y-crystallin irradiated at 325 nm; lane 2, 
y-crystalhn irradiated at 332 nm; lane 3, y-crystallin irradiated at 325 
nm in the presence of 1 mM 4-hydroxyquinohne; lane 4, y-crystallin 
irradiated at 332 nm in the presence of 1 mM kynurenic acid. The arrow 
points to higher molecular weight products. 
and also found in mitochondria of rat liver [34]. To the 
best of our knowledge [35], ours is the first report of any 
quinoline derivative being found in the lens. 
3.3. Photodynamic properties of the parent 
4-hydroxyquinoline 
Many of the pigments that accumulate in the lens 
extend the absorption range from the UVB into the UVA 
and even the visible range. Apart from the color bias that 
they introduce to the transmission of light, some of them 
can also act as photodynamic agents which, upon ab- 
sorption of UVA and visible light, cause sensitized cova- 
lent chemical changes in the substrate molecules through 
the generation of reactive oxygen species (ROS) such as 
singlet oxygen (‘0,) superoxide anion radical (O;-), hy- 
droxyl radical (‘OH) or peroxide (H,O,). We have shown 
earlier that, among the Trp oxidation products, NFK 
and KUA are particularly active photodynamic agents, 
while Ky and 3HK are benign [36]; indeed, 3HK might 
even be an endogenous antioxidant [37]. In this connec- 
tion, it is of interest to investigate whether compound A 
can act as a photodynamic agent and cause further dam- 
age to the lens. 
Since the amount of compound A purified and studied 
was in limiting amounts (2 mg isolated from 1650 mg of 
insoluble wet material from 9 lenses), we could not study 
its photodynamics directly. As a close approximation, 
the photosensitization behavior of 4-hydroxyquinoline 
was studied, since the basic moiety of this parent com- 
pound is the same as that in compound A. This was 
compared with the photosensitization behaviour of 
KUA. Both these samples were seen not to produce ‘OH 
radicals. However, these samples are quite effective in 
generating O;- radicals upon irradiation with light corre- 
sponding to their excitation maxima. No cytochrome c 
reduction was noted in the reaction mixture kept in the 
dark. 
Fig. 5 shows assays of the photodynamic ability of 
4-hydroxyquinoline and KUA to produce non-disulfide 
covalent crosslinks in y-crystallin molecules, which con- 
stitute the major fraction of the core region of mammal- 
ian eye lenses. Higher molecular weight bands are seen 
in lanes 3 and 4, indicating the presence of covalent 
non-disulfide crosslinking of y-crystallin. This result sug- 
gests that the 4-hydroxyquinoline moiety of compound 
A can act as a sensitizer (just as KUA does), active in 
UVA light, and promote covalent protein aggregation. 
The glycine substituent at position 3 would not be 
expected to alter the sensitization behavior, and thus 
compound A itself may well act as an endogenous photo- 
damaging agent. (It must be noted, however, that while 
2-amino-3-hydroxyacetophenone is a sensitizer, its O-p- 
D-glucoside, isolated by ethanolic potash extraction from 
human lens insoluble protein fraction, is not only photo- 
dynamically inert, but may also act as an antioxidant 
$7,381). 
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